HIV Among Drug Using Populations: A Global Perspective
July 23, 2010
For more information on this session, including access to speaker presentations, please see the conference Programme-at-a-Glance.
The International AIDS Society (IAS) in collaboration with the National Institute on Drug Abuse (NIDA) convened a global consultation meeting on prevention and treatment of HIV and AIDS among drug using populations from 11-12 January 2010 in Washington, DC. The goal of this symposium is to present key outcomes from the consultation meeting to HIV and AIDS scientists attending the AIDS 2010. The session is intended to advance understanding of the neurobiology of drug use and HIV risk behavior, the role of substance abuse treatment as HIV prevention-pharmacological and behavioral therapies, the "Seek, Test, Treat and Retain" strategy, the elements of comprehensive HIV prevention in substance users, particularly injecting drug users. The symposium will also provide an overview of PEPFAR's Evolving Strategy to Prevent HIV among Persons Who Inject Drugs. At the conclusion of the joint IAS/NIDA Symposium IAS/NIDA fellowships will be awarded.
Presentations in This Session:
Drug Addiction: a Brain Disease Associated with High Risk Behavior
PEPFAR's Evolving Strategy to Prevent HIV Among Persons Who Inject Drugs
Substance Abuse Treatment is HIV Prevention
HAART as Prevention for Injecting Drug Users
Concluding Remarks and Award Granting
Nora Volkow (United States)
Survival of HIV-Infected Injection Drug Users (IDUs) in the Highly Active Antiretroviral Therapy Era, Relative to Sex- and Age-Specific Survival of HIV-Uninfected IDUs
This article was provided by Henry J. Kaiser Family Foundation. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.